Electronic Cigarette and Surgery (ECigarSurg)

Smoke Inhalation Clinical Trial

— ECigarSurg  

Official title:

Electronic Cigarette and Perianesthesia : a Prospective Multicentric Survey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03594643
• Other study ID #: 2017-Ecig-Nimes
• Status: Completed
• Start date: June 1, 2016
• Est. completion date: December 30, 2017

Study information

• Verified date: July 2019
• Source: Centre Hospitalier Universitaire de Nimes
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Since decades, literature has shown that smoking has negative effect on postoperative outcome. Recent systematic review and meta-analysis on clinical impact of smoking and smoking cessation showed that postoperative healing complications occur more often in smokers compared with nonsmokers.

The use of electronic cigarette (e-cigarette) is spreading through the world. Despite this fact, the health risk assessment studies on e-cigarette are limited and scientific evidences are inconsistent.

This prospective multicenter study aimed at assessing the use of e-cigarette whether patient undergoing elective surgery. The main objective of this study was to evaluate the prevalence of e-cigarette consumer in perioperative period. Secondary objectives were to analyze when patients consume e-cigarette in regard of surgery, how many dose they consume and if they also consume nicotine cigarette.

Description:

this study used a standardized questionnaire that was filled in preoperative period

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1700
• Est. completion date: December 30, 2017
• Est. primary completion date: December 30, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• protocol approval

• patients scheduled for elective surgery

Exclusion Criteria:

• < 18 ans

• refusal

• not speaking

• emergency surgery

Related Conditions & MeSH terms

• Smoke Inhalation
• Smoke Inhalation Injury

Locations

Country	Name	City	State
France	Cuvillon	Nîmes	Gard

Sponsors (2)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nimes	Institut du Cancer de Montpellier - Val d'Aurelle

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	electronic cigarette	incidence of electronic cigarette that are used by patients	1 day